1074-1075 / 2953
Crude local control rates (2 years) redrawn from a pooled analysis
reported by Mehta et al (3D-CRT and SABR regimens)
Biological Challenges to the 5 Rs for SABR
Dose Escalation, not “new biology,” can account for the efficacy of
stereotactic body radiation therapy with non-small cell lung cancer
Brown et al, IJROBP 2014